Atheroscleroses, Coronary
15
3
5
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
Gut Microbiota Modulation With Synbiotics After Acute Coronary Syndrome
Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease
Evaluating the Impact of 'Tertinat' on Patients with Atherosclerosis-Related Cardiovascular Diseases
Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms
Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction
Concurrent OCT and FFR-guided PCI in CAD
First-In-Human Intracoronary OCT-FLIm In Patients Undergoing PCI
Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
Distal vs. Forearm Radial Artery Access
Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation
Systemic, Pancoronary and Local Coronary Vulnerability
Effect Of Semaglutide In Coronary Atheroma Plaque
The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)